Company profile
VSee Health, Inc.
NASDAQ: VSEE · Healthcare · Medical - Healthcare Information Services
#583 of 1,418 Healthcare companies by revenuetop-quartile growth
EA Score
35DFH 43DQ 5GM 69SS 38
v0.1 · 65/100 weight · provisional
↑ 3-yr revenue growth, revenue growth (YoY) · ↓ filing timeliness, disclosure history
Methodology →Revenue TTM
$14.5M
Rev growth YoY (TTM)
+18.0%
Net income (FY)
-$14.7M
Employees
209
as of 2026-08-25
Market cap
$390.3k
as of 2026-08-25
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$14.6M$14.6M2025
Net income-$14.7M-$14.7M2025
Operating income-$9.6M-$9.6M2025
Total assets$22.4M$22.4M2025
Liabilities$17.0M$17.0M2025
Equity$5.5M$5.5M2025
Revenue trend
FY2024 – FY2025 · USD
FY24
FY24
FY24
FY24
FY24
FY24
FY24
FY25
Revenue by segment
Filed disclosures · FY2024
By product
Subscription and Circulation56%
Technology Service27%
Health Care, Patient Service17%
By geography
Not disclosed.
The read
What is VSee Health, Inc.’s revenue?
VSee Health, Inc. booked $14.6M in FY2025 revenue, growing 40% year over year — faster than most Healthcare companies we track, at a -100.6% net margin.
Peers · Healthcare
Neuphoria Therapeutics Inc.44DRelay Therapeutics, Inc.57CAllurion Technologies Inc.26DLineage Cell Therapeutics, Inc.56CSunniva Inc.——Urologix, Inc.——Neighbors
Middlesex →Key facts
CEOImoigele Aisiku
SectorHealthcare
IndustryMedical - Healthcare Information Services
HeadquartersNewton, MA
ExchangeNASDAQ: VSEE
Employees209
IPO date2021-12-31
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.